Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.17 (
MMP-3
)
3,419
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent research found that
Tiron
was an effective antioxidant that could act as the intracellular reactive oxygen species (ROS) scavenger or alleviate the acute toxic metal overload in vivo. In this study, we investigated the inhibitory effect of
Tiron
on matrix metalloproteinase (MMP)-1 and
MMP-3
expression in human dermal fibroblast cells. Western blot and ELISA analysis revealed that
Tiron
inhibited ultraviolet B (UVB)-induced protein expression of MMP-1 and
MMP-3
. Real-time quantitative PCR confirmed that
Tiron
could inhibit UVB-induced mRNA expression of MMP-1 and
MMP-3
. Furthermore,
Tiron
significantly blocked UVB-induced activation of the MAPK signaling pathway and activator protein (AP)-1 in the downstream of this transduction pathway in fibroblasts. Through the AP-1 binding site mutation, it was found that
Tiron
could inhibit AP-1-induced upregulation of MMP-1 and
MMP-3
expression through blocking AP-1 binding to the AP-1 binding sites in the MMP-1 and
MMP-3
promoter region. In conclusion,
Tiron
may be a novel antioxidant for preventing and treating skin photoaging UV-induced.
...
PMID:Tiron Inhibits UVB-Induced AP-1 Binding Sites Transcriptional Activation on MMP-1 and MMP-3 Promoters by MAPK Signaling Pathway in Human Dermal Fibroblasts. 2748 52